Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma

Qian-Xiao Huang,Jun-Long Liang,Qi-Wen Chen,Xiao-Kang Jin,Mei-Ting Niu,Cheng-Yuan Dong,Xian-Zheng Zhang
DOI: https://doi.org/10.1016/j.nantod.2023.101911
IF: 17.4
2023-06-18
Nano Today
Abstract:Glioblastoma (GBM) is an aggressive brain cancer with an immunosuppressive tumor microenvironment. Here, a copper-based nanoplatform @DDM (BCMD) is constructed for mediating cuproptosis and subsequently promoting immunotherapy of glioblastoma. Specifically, BCMD can be degraded in the slightly acidic tumor environment to release Cu 2+ , which will be further reduced to toxic Cu + to induce cuproptosis under the regulation of high level of ferredoxin 1 (FDX1). Meanwhile, buthionine-sulfoximine (BSO) and catalase (CAT) released from BCMD can reduce the glutathione (GSH) synthesis and increase O 2 content in tumor cells, thereby rendering the tumor cells more sensitive to BCMD-mediated cuproptosis. In vivo experiments show that BCMD mediated cuproptosis can trigger the immunogenic cell death (ICD) to increase the infiltration of cytotoxic T lymphocytes and reverse the immunosuppressive microenvironment of glioblastoma to enhance tumoricidal immunity. Furthermore, anti-tumor therapeutic efficiency of immune checkpoint blockade (ICB) therapy is significantly enhanced by combining BCMD with αPD-L1.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?